P289 Bowel Stiffness Assessed by Shear-wave Ultrasound Elastography Predicts Disease Behavior Progression in Patients with Crohn’s Disease

J He,Y Chen,M Chen,X Xie,R Mao

DOI: https://doi.org/10.1093/ecco-jcc/jjad212.0419

2024-01-01

Journal of Crohn's and Colitis

Abstract:Abstract Background There is a lack of reliable predictors of disease behavior progression in patients with Crohn’s disease (CD). Real-time shear-wave elastography (SWE), a novel method for evaluating tissue stiffness, is reportedly helpful in determining the prognosis of liver cirrhosis or breast cancer. However, its value for assessing CD has not yet been investigated. We aimed to explore the value of SWE and other ultrasound parameters at diagnosis in predicting CD behavior progression. Methods We retrospectively collected data from CD patients with the non-stenotic non-penetrating disease (B1 phenotype based on the Montreal classification). All patients underwent intestinal ultrasound with SWE measurement at baseline and were followed up. The endpoint was defined as disease behavior progression to stricturing (B2) or penetrating (B3) disease. A multivariate Cox regression model was used to explore the association between baseline SWE and subsequent outcome. We also established a multivariate nomogram to predict the risk of disease behavior progression and evaluated its performance with receiver operating characteristic curve and decision curve analysis. Results A total of 130 CD patients with B1 phenotype were enrolled. Twenty-seven patients (20.8%) developed B2 or B3 disease, with a median follow-up of 33 months. Multivariate analysis identified that SWE ≥12.75 kPa was the only independent predictor of disease behavior progression (HR 1.08, 95% CI 1.03-1.12, P=0.001, Fig 1A). A restricted cubic spline with multiple covariates adjusted showed an approximately linear positive correlation between SWE and the risk of disease behavior progression, with a cut-off of 12.75 kPa (Fig 1B). We further established a multivariate nomogram incorporating SWE and other clinical characteristics to predict the risk of disease behavior progression quantitatively (Fig 1C). Compared to the model composed solely of SWE, the multivariate nomogram showed a higher but less significant performance (0.738 vs. 0.792, p=0.169, Fig 1D). However, the decision curve analysis showed that the model outperformed the single indicator of SWE in predicting endpoint events, especially those occured after 12 months of baseline (Fig 1E). Conclusion Intestinal stiffness assessed using SWE is an independent predictor of disease behavior progression in patients with CD. CD patients with SWE ≥12.75 kPa at diagnosis are prone to progress toward stricturing or penetrating diseases, which warrants timely intervention.

gastroenterology & hepatology

What problem does this paper attempt to address?

This paper aims to solve the problem of predicting the progression of disease behavior in patients with Crohn's Disease (CD). Specifically, at present, there is a lack of reliable indicators to predict whether the disease behavior of Crohn's disease patients will progress from non - stricturing non - penetrating type (B1 phenotype) to stricturing type (B2) or penetrating type (B3). Researchers attempt to use Shear - wave Ultrasound Elastography (SWE), a new technology, to evaluate intestinal stiffness and explore its value in predicting the progression of disease behavior in Crohn's disease patients.

The research background indicates that SWE is a new method for evaluating tissue stiffness and has shown certain value in the prognosis judgment of liver cirrhosis and breast cancer. However, its application in Crohn's disease has not been fully studied. Therefore, the main objective of this study is to explore the predictive value of SWE and other ultrasound parameters for the progression of disease behavior at the time of diagnosis in Crohn's disease patients.

By retrospectively collecting data and conducting a multivariate Cox regression analysis, the study found that an SWE value ≥ 12.75 kPa was the only independent factor predicting the progression of disease behavior (hazard ratio HR 1.08, 95% confidence interval CI 1.03 - 1.12, P = 0.001). In addition, the study also established a multivariate nomogram including SWE and other clinical features to quantitatively predict the risk of disease behavior progression, further verifying the effectiveness of SWE in predicting the progression of disease behavior in Crohn's disease patients.

The conclusion part emphasizes that intestinal stiffness evaluated by SWE is an independent predictor of the progression of disease behavior in Crohn's disease patients. For Crohn's disease patients with an SWE value ≥ 12.75 kPa, they are more likely to develop into stricturing or penetrating diseases, which indicates the need for timely intervention measures.